ケニア - 英語 - Pharmacy and Poisons Board

regal pharmaceuticals limited regal pharmaceuticals limited 7879/18 off baba - salbutamol (as sulphate ) - syrup - salbumol syrup - adrenergics for systemic use: selective

フィリピン - 英語 - FDA (Food And Drug Administration)

penta labs australia (philippines) - salbutamol (as sulfate) - syrup - 2mg / 5ml

バングラデシュ - 英語 - DGDA (Directorate General of Drug Administration)

indo-bangla pharmaceuticals ltd. - salbutamol - tablet - 2 mg

バングラデシュ - 英語 - DGDA (Directorate General of Drug Administration)

indo-bangla pharmaceuticals ltd. - salbutamol - syrup - 2 mg/5 ml

タンザニア - 英語 - Tanzania Medicinces & Medical Devices Authority

regal pharmaceuticals limited, kenya - salbutamol - syrup - 2mg/5ml

ウガンダ - 英語 - National Drug Authority

regal pharmaceuicals ltd - salbutamol - oral liquid ordinary syrups - 2mg/5ml

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

カナダ - 英語 - Health Canada

ratiopharm inc division of teva canada limited - salbutamol (salbutamol sulfate) - metered-dose aerosol - 100mcg - salbutamol (salbutamol sulfate) 100mcg - selective beta 2-adrenergic agonists